Our finding that an augmentation of the PD-1 pathway leads to a worse prostate cancer prognosis may indicate that tumor immune escape, and thus tumor immune elimination, are important mechanisms in prostate cancer. This evidence concerns the gene PDCD1 and Familial prostate cancer.